Starting July 1, some HIV meds that are widely used will be excluded from their list.
Advocates say the move is more politics than science.
Our HIV research agenda has to address the world outside of a clinical trial, vaccine researcher Stephaun E. Wallace, Ph.D., argues.
Best practices need to be replicated, but our health care structure will make doing so more challenging, says Ace Robinson of the Fast-Track Cities initiative.
Anthony J. Santella, Dr.P.H., explains why prevention efforts are lagging within the largest suburban HIV epidemic in the U.S.
Providers, payers, and health systems need to catch up, said Melanie Thompson, M.D., at the ACTHIV conference.
Looking back on Poteat’s professional arc, it can appear as though her path toward a leadership role in HIV care was always clear. But there have been plenty of twists in that path.
As the 2019 National HIV Prevention Conference kicked off on March 18, plenary speakers discussed not only recent biomedical advances, but also what is truly needed in heavily affected U.S. communities to end the epidemic.
This study identified some information about transgender women's sexual networks in Los Angeles. But activists worry about privacy and the potential that the surveillance method will be used in HIV criminalization cases.
While Ralph Northam's medical school photo in blackface is a political scandal, it is important that we not lose sight of how provider racism in medicine endangers the lives of black people seeking care, especially when living with HIV.